Track Chair - CRISPR/Cas technologies from discovery to therapeutic application
ELRIG Drug Discovery 2026 · 14 October 2026 · 11:15–11:20 · Tech Theatre
Track Chair - CRISPR/Cas technologies from discovery to therapeutic application was a session at ELRIG Drug Discovery 2026 on 14 October 2026 in London, with 2 speakers on record.
Speakers
- Ulrike Künzel — Chair Associate Principal Scientist, Astrazeneca
- Ming Jiang — Chair Deputy Head Of Screening and Automated Science, The Francis Crick Institution